Genetics

Potential new biomarker for Alzheimer's discovered

Alzheimer's is considered a disease of old age, with most people being diagnosed after 65. But the condition actually begins developing, out of sight, many years before any symptoms emerge. Tiny proteins, known as amyloid-beta ...

Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

Diseases, Conditions, Syndromes

Gonorrhea shot gets FDA fast track as resistant cases multiply

GSK Plc's experimental gonorrhea vaccine got fast-track designation from U.S. regulators, putting the shot in position to become the first preventive for a common, often-undetected infection that's gaining resistance to treatment.

Diseases, Conditions, Syndromes

Asymptomatic testing key to pandemic preparedness, new study finds

Asymptomatic PCR testing for NHS staff, provided by the Francis Crick Institute and University College London Hospitals (UCLH) NHS Foundation Trust and its diagnostic partner Health Services Laboratories, effectively detected ...

page 7 from 40